UROGEN PHARMA CFO’s Fresh Buy Signals Investor Confidence Amid Tumultuous Market Drop
UroGen Pharma’s CFO buys shares amid a steep decline, signaling confidence in its uro‑oncology pipeline and potential upside for investors.
3 minutes to read
UROGEN PHARMA LTD